After the transaction, Van Plew Daniel P's stake was reported as 4,784 shares of Regeneron Pharmaceuticals Inc stock.
As noted on November 16, 2012, Van Plew Daniel P's sale was done directly over 6 transactions on November 16, 2012. The share price ranged from $153.48 to $157.44 according to the regulatory filing detailing the transactions.
If we look over the past 12 months, Van Plew Daniel P has sold a total of 18,741 shares of Regeneron Pharmaceuticals Inc, proceeds from the sale totaled $2,917,899. Over the same time period, Van Plew Daniel P has purchased no shares of Regeneron Pharmaceuticals Inc stock.
Let's take a quick, high-level look at insider trading at Regeneron Pharmaceuticals Inc over the past 12 months. A total of 944,217 shares of Regeneron Pharmaceuticals Inc stock was sold by insiders, totaling $108,668,461. Over the same time 12 month time period, no shares of Regeneron Pharmaceuticals Inc were purchased by company insiders.
To view the complete SEC Filing: Regeneron Pharmaceuticals Inc Form 4 (Insider Trading) SEC Filing
